INT274879

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.13
First Reported 2009
Last Reported 2009
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 2
Disease Relevance 0
Pain Relevance 0.28

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

Cbr2 (Rattus norvegicus)
Pain Link Frequency Relevance Heat
antagonist 20 99.64 Very High Very High Very High
agonist 20 99.60 Very High Very High Very High
imagery 2 84.84 Quite High
Inflammation 42 50.00 Quite Low
Cannabinoid receptor 12 50.00 Quite Low
Cannabinoid 12 37.00 Quite Low
Peripheral nerve injury 12 5.00 Very Low Very Low Very Low
Central nervous system 8 5.00 Very Low Very Low Very Low
Neuropathic pain 8 5.00 Very Low Very Low Very Low
Endocannabinoid 6 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
INFLAMMATION 46 50.00 Quite Low
Nervous System Injury 18 5.00 Very Low Very Low Very Low
Neuropathic Pain 14 5.00 Very Low Very Low Very Low
Pain 10 5.00 Very Low Very Low Very Low
Hypersensitivity 10 5.00 Very Low Very Low Very Low
Necrosis 6 5.00 Very Low Very Low Very Low
Cancer 6 5.00 Very Low Very Low Very Low
Frailty 4 5.00 Very Low Very Low Very Low
Neurological Disease 2 5.00 Very Low Very Low Very Low
Diabetes Mellitus 2 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
To test the specificity of the CBR2 agonist, we challenged its effects with specific CBR1 (AM281) and CBR2 (AM630) antagonists by using the following groups: LPS + JWH015 (1 ?
CBR2 Binding (specific) of associated with antagonist and agonist
1) Confidence 0.13 Published 2009 Journal Mol Pain Section Body Doc Link PMC2704199 Disease Relevance 0 Pain Relevance 0.14
To test the specificity of the CBR2 agonist, we challenged its effects with specific CBR1 (AM281) and CBR2 (AM630) antagonists by using the following groups: LPS + JWH015 (1 ?
CBR2 Binding (effects) of associated with antagonist and agonist
2) Confidence 0.13 Published 2009 Journal Mol Pain Section Body Doc Link PMC2704199 Disease Relevance 0 Pain Relevance 0.14

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox